Skip to Content

Drug Interactions between bcg and sarilumab

This report displays the potential drug interactions for the following 2 drugs:

  • bcg
  • sarilumab

Edit list (add/remove drugs)

Interactions between your drugs


BCG sarilumab

Applies to: bcg and sarilumab

If you are currently being treated or have recently been treated with sarilumab, you should let your doctor know before receiving BCG. Depending on the dose and length of time you have been on sarilumab, you may be at risk for developing an infection from BCG or have a reduced response to BCG. In some situations, your doctor may want to delay treatment with BCG to give your body time to recover from the effects of sarilumab therapy. Additionally, since the bacteria in BCG may persist in the urinary tract for months after treatment, you may still be at increased risk for infection even if you receive sarilumab after you have stopped treatment with BCG for some time. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.